230 related articles for article (PubMed ID: 15570297)
1. Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.
Ramachandran A; Majumdar G
Hematol J; 2004; 5(6):528-9. PubMed ID: 15570297
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.
Hussain K; Mazza JJ; Clouse LH
Am J Hematol; 2003 Mar; 72(3):212-5. PubMed ID: 12605395
[TBL] [Abstract][Full Text] [Related]
3. Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.
Cheson BD; Frame JN; Vena D; Quashu N; Sorensen JM
J Clin Oncol; 1998 Jul; 16(7):2313-20. PubMed ID: 9667245
[TBL] [Abstract][Full Text] [Related]
4. Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.
Calvo-Villas JM; Urcuyo BM; Umpierrez AM; Sicilia F
Onkologie; 2008 Apr; 31(4):197-9. PubMed ID: 18418022
[TBL] [Abstract][Full Text] [Related]
5. Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.
Rioufol C; Coiffier B
Onkologie; 2008 Apr; 31(4):157-8. PubMed ID: 18418014
[No Abstract] [Full Text] [Related]
6. Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.
Mulligan SP; Dean MG
Aust N Z J Med; 1994 Aug; 24(4):406-7. PubMed ID: 7980241
[No Abstract] [Full Text] [Related]
7. Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
Montalban C; Liaño F; Aguilera A
Postgrad Med J; 1994 Sep; 70(827):651-2. PubMed ID: 7971632
[TBL] [Abstract][Full Text] [Related]
8. Tumor lysis syndrome in a chronic lymphocytic leukemia patient with pleural effusion after oral fludarabine and cyclophosphamide therapy.
Nakazawa H; Nishina S; Mimura Y; Kawakami T; Senoo Y; Sakai K; Nakazawa K; Kitano K
Int J Hematol; 2014 Jun; 99(6):782-5. PubMed ID: 24584911
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.
Frame JN; Dahut WL; Crowley S
N Engl J Med; 1992 Nov; 327(19):1396-7. PubMed ID: 1406856
[No Abstract] [Full Text] [Related]
10. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
Hummel M; Buchheidt D; Reiter S; Bergmann J; Adam K; Hehlmann R
Eur J Haematol; 2005 Dec; 75(6):518-21. PubMed ID: 16313266
[TBL] [Abstract][Full Text] [Related]
11. Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.
Dizdar O; Yürekli BS; Pürnak T; Aksu S; Haznedaroglu IC
Ann Pharmacother; 2004; 38(7-8):1319-20. PubMed ID: 15138295
[No Abstract] [Full Text] [Related]
12. Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia.
Ural AU; Kubar A; Avcu F; Tastan HB; Safali M; Nevruz O; Cetin T
Clin Exp Dermatol; 2007 Mar; 32(2):151-4. PubMed ID: 17244344
[TBL] [Abstract][Full Text] [Related]
13. Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Macheta MP; Parapia LA; Gouldesbrough DR
J Clin Pathol; 1995 Feb; 48(2):181-2. PubMed ID: 7745121
[TBL] [Abstract][Full Text] [Related]
14. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
16. Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
Laurenti L; De Padua L; Tarnani M; Piccirillo N; Falcucci P; D'Arena G; Innocenti I; Marietti S; Efremov DG; Chiusolo P; Zini G; Sora' F; Sica S; Leone G
Ann Hematol; 2011 Jan; 90(1):59-65. PubMed ID: 20625902
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
MacCallum S; Groves M; Brass D; Cunningham J; Sales M; Gelly K; Tauro S
J Clin Pathol; 2009 May; 62(5):468-70. PubMed ID: 19398596
[TBL] [Abstract][Full Text] [Related]
18. Oral fludarabine therapy in chronic lymphocytic leukemia--increased convenience.
Boogaerts MA
Hematol J; 2004; 5 Suppl 1():S31-7. PubMed ID: 15079151
[TBL] [Abstract][Full Text] [Related]
19. Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
List AF; Kummet TD; Adams JD; Chun HG
Am J Med; 1990 Sep; 89(3):388-90. PubMed ID: 1697447
[No Abstract] [Full Text] [Related]
20. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
